SEC Filing Details

Document Details

Form
Filing Date
November 19, 2019
Document Date
November 19, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Jasper Therapeutics, Inc
Issuer
JASPER THERAPEUTICS, INC.
Filer
ESHELMAN FREDRIC N
Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.